BioSpace News Archive

Drug Development

Can Olema Oncology Prevail Where Other SERDs have Recently Failed?

Olema president and CEO Sean Bohen spoke with BioSpace about why he believes his company’s approach with a SERD and ER antagonist can successfully treat an advanced form of breast cancer.

June 18, 2022
·
4 min read
·
Alex Keown
Drug Development

Janssen Recruiting for Phase III Trials of Potential Myasthenia Gravis Game Changer

BioSpace spoke with Janssen’s Fiona Elwood about the company’s myasthenia gravis candidate nipocalimab, which is currently recruiting for two Phase III trials.

June 18, 2022
·
4 min read
·
Gail Dutton
Bio NC

Texas Children’s Hospital To Begin Safely Administering COVID-19 Vaccines to Children Aged 6 months to 5 years

Beginning Tuesday, June 21, Texas Children’s Hospital will begin administering both the Pfizer and Moderna COVID-19 vaccines to children aged 6 months to 5 years, following FDA emergency-use authorization and recommendations for safe administration from the CDC.

June 18, 2022
·
3 min read
Bio NC

Walgreens Now Providing Pfizer and Moderna COVID-19 Vaccines to Children Ages 3 and Older at Select Locations Nationwide

Walgreens will begin administering Pfizer and Moderna COVID-19 vaccines to children aged 3 years and older at select locations nationwide following FDA Emergency Use Authorization and new guidance from the Centers for Disease Control and Prevention that children as young as six months are eligible to receive a Pfizer or Moderna COVID-19 vaccine.

June 18, 2022
·
5 min read